Cervical Cancer and HPV Research
Cervical Cancer and HPV Research is a research topic within Epidemiology. Science Explorer counts 56k research works in it since 1950. 14.4% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the epidemiology, burden, and prevention of cervical cancer associated with Human Papillomavirus (HPV) infection. It covers topics such as HPV vaccination, viral oncogenes, genotype distribution, cytology screening, and the global burden of HPV-related cancers.
- Human Papillomavirus
- Cervical Cancer
- HPV Vaccination
- Epidemiology
- Cancer Incidence
- Cytology Screening
- Viral Oncoproteins
- Carcinogenicity
- Genotype Distribution
- Global Burden
- Research works
- 56k fractional, since 1950
- In the world top 10%
- 8.1k per year above
- Top-10% rate
- 14.4% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +19% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Cervical Cancer and HPV Research research?
By volume, the United States and China publish the most (2.2k and 1.2k works in 2022–2025).
By volume, 2022–2025
- 1 United States 2.2k works
- 2 China 1.2k works
- 3 India 809 works
- 4 Brazil 353 works
- 5 United Kingdom 324 works
- 6 Italy 267 works
- 7 Türkiye 251 works
- 8 Japan 235 works
- 9 Germany 212 works
- 10 Nigeria 208 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Cervical Cancer and HPV Research research?
By volume in 2022–2025, University of North Carolina at Chapel Hill publishes the most Cervical Cancer and HPV Research research, followed by Chinese Academy of Medical Sciences & Peking Union Medical College and The University of Texas MD Anderson Cancer Center.
By volume, 2022–2025
- 1 University of North Carolina at Chapel HillUnited States 137 works
- 2 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 44 works
- 3 The University of Texas MD Anderson Cancer CenterUnited States 43 works
- 4 Johns Hopkins UniversityUnited States 30 works
- 5 All India Institute of Medical SciencesIndia 25 works
- 6 National Cancer InstituteUnited States 24 works
- 7 University of WashingtonUnited States 24 works
- 8 University of MichiganUnited States 24 works
- 9 University of Southern CaliforniaUnited States 24 works
- 10 Karolinska InstitutetSweden 23 works
Who are the leading researchers in Cervical Cancer and HPV Research?
The most-cited researchers publishing on Cervical Cancer and HPV Research include Ahmedin Jemal.
- 1 Ahmedin Jemal United States 4.9k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Cervical Cancer and HPV Research research done?
The largest centres of Cervical Cancer and HPV Research research in 2022–2025 are Beijing (China), Chapel Hill (United States), London (United Kingdom) and Shanghai (China). Among places with at least 20 works in it, it is an unusually large share of all research in San Juan.
Largest cities, 2022–2025
Where it is the local speciality
- San JuanPR · 29.3 works15×
Location quotient: how much more of its research is in Cervical Cancer and HPV Research than the world average.
Where is the best place to study Cervical Cancer and HPV Research?
Among universities, judged by research, London School of Hygiene & Tropical Medicine, University of Gondar and University of North Carolina at Chapel Hill score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | London School of Hygiene & Tropical MedicineUnited Kingdom | 65.9 | 38.3% | 9.5× | 14 | +53.9% |
| 2 | University of GondarEthiopia | 60.9 | 48.1% | 8.3× | 12 | — |
| 3 | University of North Carolina at Chapel HillUnited States | 53.4 | 4.9% | 8.2× | 137 | +106.5% |
| 4 | Addis Ababa UniversityEthiopia | 46.4 | 19.4% | 5.5× | 13 | +440.7% |
| 5 | Karolinska InstitutetSweden | 46.3 | 26.8% | 5.4× | 23 | -1.2% |
| 6 | Medical University of WarsawPoland | 44.1 | 19.4% | 5.3× | 12 | +234.9% |
| 7 | The University of Texas Health Science Center at HoustonUnited States | 43.8 | 20.2% | 7.1× | 20 | +42.7% |
| 8 | Dhaka Medical College and HospitalBangladesh | 43.8 | 1.6% | 9.9× | 9 | +224.7% |
| 9 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 43.7 | 22.4% | 4.6× | 44 | +40.4% |
| 10 | Institute of Medical SciencesIndia | 42.8 | 1.4% | 7.5× | 23 | +441.4% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Cervical Cancer and HPV Research research growing?
Output in 2018–2022 was 19% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Cervical Cancer and HPV Research.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.